healthcare it feeds raw « World Post News
World Post News
  • Freedom Watch Facebook

  • Freedom Watch Twitter

Category Archives: healthcare it feeds raw

Forecast and Ramifications of Payers in the HIE Market: Part One

The numerous changes in the healthcare sector are forcing stakeholders to develop new business models to prosper, to survive. Among health insurers, this means one thing: diversification. Health reform was the nail in the coffin of yesterday’s business model, a model that…

Global Dissemination of Healthcare Technology

The dissemination of healthcare treatment through the developed world is at the inception of extending successful implementation strategies in the developing world. The implementation of healthcare… As a leading provider of services in the healthcare industry, Perficient has delivered both strategic…

Interoperability Infrastructures: Enabling healthcare quality measures

There is no doubt that the healthcare industry is going through a tremendous paradigm shift in an attempt to get a grasp on rising costs and inefficiencies. From ACOs, pay for performance, Meaningful… As a leading provider of services in the healthcare industry, Perficient has delivered…

A Real Periodic Table – With Real Elements

Here’s a YouTube look at a periodic table, laid out with high-quality samples of the real elements. I want one, although I’m willing to compromise on some of the radioactive items; completeness can be taken a bit too far. It’s from the folks at PeriodicTable.com , featuring…

When Reagents Attack!

Well, since I was just talking about a reagent that can potentially take off without warning, I wanted to solicit vivid experiences from the crowd. What’s a…

That Academic-Industrial Collaboration Panel

Here’s the streaming video of the session I did at SLAS2012 on collaboration between academia and industry. I’m not sure how long it’ll be up, so if you want to see it, you probably should go ahead and check it out. A lot of people probably wish they could fast…

Who’s Data is it Anyway?

Chilmark Research tends to shy away from the thorny, nearly intractable issues of privacy and security of Personal Health Information (PHI) (we’ll leave that to the lawyers and policy wonks to figure out). However one thing is very clear: …

The Importance of Being Earnest about Security in Healthcare, Part 2

First, let me start with questions I asked at the close of Part 1.  How does your organization manage security and its risks?  Do you have a governance process in place, is it comprehensive,… As…

Nobel Prizes in Chemistry For People Who Aren’t Chemists

Nobelist Roald Hoffman has directly taken on a topic that many chemists find painful: why aren’t more chemistry Nobel prizes given, to, well. . .chemists? “. . .the last decade has been especially unkind to “pure” chemists, asa only four of ten Nobel awards could be…

Pfizer Layoff This Past Weekend?

I’m hearing stories that there was a layoff (yet again) at Pfizer, this time affecting the Cambridge researchers. Word is that they got the word over the weekend , which

Synthetic Electrochemistry: Who’s Done Any?

Looking through the literature this morning, I thought about another technique that, although you see it published on, no organic chemist I know has ever actually used: electrochemistry . There are all sorts of odd reactions that can apparently be made …

Receiving Outcome Incentive Payments Requires more than “Outcomes” from Providers

Paying healthcare providers to meet defined quality goals has experienced an uptick in acceptance and appeal lately.  Given the fact that the quality of care in the United …

Creating your EDI mapping layout

In the previous blog we discussed the importance of knowing your data and business requirement needs. This is one place where that becomes important. If you already know your …

Bexarotene for Alzheimer’s

Here’s another intriguing Alzheimer’s result, in a field that could certainly use some. A group at Case Western (no, not the gyre guy) has reported on the effects of the RXR ligand Bexarotene (brand name Targretin) in several different mouse models of the disease. Dosing with…

The Infinitely Active Impurity

The Infinitely Active Impurity

Everyone who’s done drug discovery has encountered this situation: you get what looks like a hit in a screening assay, but when you re-check it with fresh material, it…

Is Direct Undercutting the Viability of RHIOs?

Is Direct Undercutting the Viability of RHIOs?

Last week, a discussion got started on Google +  by Brian Ahier about whether or not ONC’s aggressive support of Direct is undercutting many a Regional Health Information Organization (RHIO). What got this whole conversation started was an article in the January …

Guidance on Biosimilars

If you’re interested, here’s the FDA’s draft of their guidance on biosimilars , up on their site today. This is a slow-moving story that’s going to end up having a big effect on the industry. Look at the number of top-selling drugs that are biologics, look at …

Blue Button – Is it time to get into the 21st century?

The VA and Medicare recently launched the Blue Button initiative where patients can “download their claims and medical information in a common format.”  This format is a plain ASCII text file with… As a leading provider of…

Oh, Say Can You ONC?

Providers and patients should be comfortable that their Health IT systems are secure, confidential, play well with other systems and functional. To enable this, the Health Information Technology for… As a leading provider of services in the healthcare industry, Perficient has delivered both strategic consulting and…

Buying Back Shares: An Admission of Defeat

Announcing layoffs along with a stock buyback – let’s think about what that means. AstraZeneca did that just the other day, and they’re far from the only ones in this industry (or others ) spending billions to buy back their own shares while they’re cutting costs elsewhere. We already…

Every Methods Paper Has a Table

Here’s a helpful translation , and there’s more truth in it than there should be. My rule of thumb is to be extremely suspicious of a methods paper that doesn’t have at least a couple of low-yielding or “NR” entries. If they aren’t …

Roger Boisjoly and the Management Hat

I’d like to take a few minutes to remember someone that everyone in R&D should spare a thought for: Roger Boisjoly, If you don’t know the name, you’ll still likely know something about his story: he was one of the Morton Thiokol engineers who tried, unsuccessfully, to…

Context is Everything

A few weeks ago, I had the opportunity to talk with an innovative company about a new product.  I make it a policy not to endorse any particular company or product on this blog, so this is not an endorsement.  Rather it is a …

Business Requirements: Don’t Say “How”

Stating how to achieve a result is normally taboo in requirements writing. The resounding “No” that causes systems personnel to cringe is when someone wants to dictate how to …

ICD-10 Revenue Neutrality: Health Outcomes and Cost

As the October 1, 2013, deadline for ICD-10 compliance gets closer, the Revenue Cycle Management will surface as the next Healthcare Organization show stopper. ICD-10 clinical specificity will better… …

Glass Structure, Atom by Atom

For a really stunning electron micrograph of the thinnest possible layer of glass, see here . (If you don’t have journal access, here’s a release with some details). What’s even more striking is that the semi-…

The Academic-Industrial Collaboration in Drug Discovery Panel: Today

As mentioned before, I’m going to be moderating a panel today on industry-academic collaborations in drug discovery at the SLAS meeting in San Diego. It starts at 10:30 AM Pacific Time, and you can access a live stream of the event here (scroll …

Let’s Start Off the Meeting With An Ad, OK?

I’m sitting in the main conference hall at the SLAS meeting as things get going. And I have to say, it’s a big crowd, and there are some very interesting things on the agenda. But I’ve just seen something I’ve never seen before: an ad being played on…

Tau Spreads On Its Own?

I’ve been meaning to mention the very interesting work that’s shown up on tau protein in Alzheimer’s. That’s generally taken a back seat to amyloid in the protein-pathologies-of-Alzheimer’s derby, but no one has been…

More Industrial Espionage

Well, we last got into arguments about industrial espionage here in December , so it’s what? February already? Then here we go: from C&E News , we have this : Federal…

How the Andrulis Paper Got Published

The editor of the journal Life has published an attempt at detailing how the notorious Andrulis paper managed to make its way into print. See how convincing you find it. In the course of …

Welcomed Changes for 2012

Since its start in 2007, Chilmark Research has kept a fairly low profile as analyst firms go, focusing on a few discrete domains of healthcare IT (HIT)…

Free February

Let you in on a little secret. February happens to be the month in which I was born. So to celebrate, I’m giving you dear readers a birthday gift. For the month of February you can get a free copy of the…

Like Healthcare Gamification? Wait until you hear about Embedded Health.

Late last night I was fortunate enough to come across an article entitled “Embedded Health: Designing Future Health Interventions Around Our Weaknesses“.  This article begins: Once we… As a leading provider of services in the healthcare industry, Perficient has delivered…

Facing and Overcoming the 2012 #HealthIT Challenges Amidst the End of the World – Part I of 2

Background Healthcare providers and eligible primary physician practices are undergoing analysis paralysis because of all the government impositions on improving healthcare with the following list of… As a …

Will Financial Dashboards Really Assist Hospital CFO’s?

In a word: YES! A hospital’s enterprise performance management program should offer proof that comparisons of actual performance against strategic objectives enable the healthcare organization to… As a leading provider of…

Smugness as a Warning Sign

At Xconomy, Luke Timmerman has words of wisdom for people in the small biotech world: “Never back smug”. That’s a quote from venture capitalist Bob More, and it …

Potassium Hydride Is Not Your Friend

Noted chem-blogger Milkshake seems to have had a close call with a fire started by a tiny potassium hydride residue. It looks like he made it…

AstraZeneca Layoffs and Closings

Update: it’s all true . 7,300 job cuts in total. Montreal and Soedertaelje (Sweden) to close. And AZ seems to be all but getting out of pain/CNS, cutting down to a few dozen…

Fluorine NMR: Why Not?

Fluorine NMR is underused in chemistry. Well, then again, maybe it’s not, but it’s one of those thing that just seems like it should have more uses than it does. ( Here’s …

  • Sponsor

  • Sponsor

Page 1 of 212»

AutoBlogged